London – May 13, 2022 – Cooley has been recognized as Venture Capital Firm of the Year at the 2022 LMG Life Sciences EMEA Awards. In addition, Cooley partners John Wilkinson and Tom Goodman were named Licensing & Collaboration Lawyer of the Year and Corporate Rising Star, respectively.
View the full list of winners
The winners were announced at a ceremony in London on May 12, 2022, that brought together Europe’s legal community to recognize the leading law firms and lawyers from across the region to celebrate their success in the life sciences industry.
LMG Life Sciences produces one of the most respected awards programs for life sciences practitioners and firms in the United States, Canada, Europe, the Middle East and Africa. The winners were determined through a rigorous research process that aims to survey excellent legal service over a 12-month period. Covered in the award categories were four key practice areas: financial & corporate, regulatory, intellectual property, and non-IP litigation & enforcement.
Cooley continues to be a top law firm for emerging and mature life sciences companies, and counsels 1,900+ public and private life sciences company clients worldwide, including nearly 50% of the Nasdaq Biotechnology Index. The firm advises on all aspects of life sciences technologies for established public companies and growing startups. Cooley has been the #1 VC law firm for biotech and pharma venture financings for the past decade and is the #1 firm for issuer-side life sciences IPOs – a title held since 2000.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe.